Table 3.
Adverse events occurring with an incidence of 10% or more higher in patients treated with palifermin compared with placebo
| Adverse event | Placebo, % | Palifermin, % | P |
|---|---|---|---|
| Edema | 65 | 78 | .15 |
| Infection | 0 | 11 | .17 |
| Local pain | 77 | 88 | .07 |
| Skin rash | 68 | 94 | <.01 |
Adverse events occurring with an incidence of 10% or more higher in patients treated with palifermin compared with placebo
| Adverse event | Placebo, % | Palifermin, % | P |
|---|---|---|---|
| Edema | 65 | 78 | .15 |
| Infection | 0 | 11 | .17 |
| Local pain | 77 | 88 | .07 |
| Skin rash | 68 | 94 | <.01 |